Suppr超能文献

在韩国使用目前可用的移植物进行血管内动脉瘤修复的可行性有限。

Limited feasibility in endovascular aneurysm repair using currently available graft in Korea.

作者信息

Bae Taeseok, Lee Taeseung, Jung In Mok, Ha Jongwon, Chung Jung Kee, Kim Sang Joon

机构信息

Department of Surgery, Seoul National University Bundang Hospital, Bundang-gu, Seongnam, Korea.

出版信息

J Korean Med Sci. 2008 Aug;23(4):651-6. doi: 10.3346/jkms.2008.23.4.651.

Abstract

Despite the wide acceptance of endovascular aneurysmal repair in patients with abdominal aortic aneurysm (EVAR), stringent morphologic criteria recommended by manufacturers may preclude this treatment in patients with AAA. The purpose of this study was to investigate how many patients are feasible by Zenith and Excluder stent graft system, which are available in Korea. Eighty-two AAA patients (71 men, mean age 70 yr) who had been treated surgically or medically from January 2005 to December 2006 were included. Criteria for morphologic suitability (MS) were examined to focus on characteristics of aneurysm; proximal and distal landing zone; angulation and involvement of both iliac artery aneurysms. Twenty-eight patients (34.1%) were feasible in Zenith stent graft and 31 patients (37.8%) were feasible in Excluder. The patients who were excluded EVAR had an average of 1.61 exclusion criteria. The main reasons for exclusion were an unfavorable proximal neck (n=34, 41.5%) and problem of distal landing zone (n=25, 30.5%). There was no statistical significance among gender, age or aneurysm size in terms of MS. Only 32 patients (39%) who had AAA were estimated to be suitable for two currently approved grafts by strict criteria. However, even unfavorable AAA patients who have severe co-morbidities will be included in EVAR in the near future. Therefore, more efforts including fine skill and anatomical understanding will be needed to meet these challenging cases.

摘要

尽管腹主动脉瘤患者对血管内动脉瘤修复术(EVAR)的接受度很高,但制造商推荐的严格形态学标准可能会使腹主动脉瘤患者无法接受这种治疗。本研究的目的是调查韩国现有的Zenith和Excluder支架移植物系统对多少患者可行。纳入了2005年1月至2006年12月期间接受手术或药物治疗的82例腹主动脉瘤患者(71例男性,平均年龄70岁)。检查形态学适用性(MS)标准,重点关注动脉瘤的特征;近端和远端锚定区;双侧髂动脉瘤的成角情况和累及情况。28例患者(34.1%)适合使用Zenith支架移植物,31例患者(37.8%)适合使用Excluder。被排除在EVAR之外的患者平均有1.61项排除标准。排除的主要原因是近端颈部情况不佳(n = 34,41.5%)和远端锚定区问题(n = 25,30.5%)。在MS方面,性别、年龄或动脉瘤大小之间无统计学意义。按照严格标准,仅有32例(39%)腹主动脉瘤患者被估计适合使用两种目前已获批的移植物。然而,即使是患有严重合并症的不利腹主动脉瘤患者在不久的将来也将被纳入EVAR。因此,需要付出更多努力,包括精湛的技术和对解剖结构的了解,以应对这些具有挑战性的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdd3/2526404/5fc76715b7d6/jkms-23-651-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验